Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
JACC. Case Reports|March 2, 2021
Reversible Coronary Artery Aneurysm With Delayed Anti-inflammatory Therapy in Multisystem Inflammatory Syndrome in ChildrenRamzi Shaykh, Shoshana Leftin, Sanghee Suh, et al.
Pediatrics|August 27, 2020
COVID-19 Inflammatory Syndrome With Clinical Features Resembling Kawasaki DiseaseRobert Spencer, Ryan C Closson, Mark Gorelik, et al.
The Journal of Allergy and Clinical Immunology|December 22, 2014
A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergySatya D Narisety, Pamela A Frischmeyer-Guerrerio, Corinne A Keet, et al.
Rheumatology International|March 8, 2021
Therapeutic approaches to pediatric COVID-19: an online survey of pediatric rheumatologistsAles Janda, Catharina Schuetz, Scott Canna, et al.
Pediatric Emergency Care|June 29, 2023
Development of a Model to Identify Febrile Children at Low Risk for Multisystem Inflammatory SyndromeTamar R Lubell, Mark Gorelik, Dori Abel, et al.
The Journal of Allergy and Clinical Immunology|October 24, 2021
Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndromeJanice J Huang, Samantha B Gaines, Mateo L Amezcua, et al.
The Journal of Allergy and Clinical Immunology|December 28, 2014
Suppression of the immunologic response to peanut during immunotherapy is often transientMark Gorelik, Satya D Narisety, Anthony L Guerrerio, et al.
Frontiers in Immunology|April 26, 2021
Inhibition of IL-6 in the LCWE Mouse Model of Kawasaki Disease Inhibits Acute Phase Reactant Serum Amyloid A but Fails to Attenuate VasculitisRebecca A Porritt, Carol Chase Huizar, Edward J Dick, et al.
ACR Open Rheumatology|July 27, 2021
Kawasaki Disease: A Systematic Review and Meta-Analysis of Benefits and Harms of Common TreatmentsKaren E James, Mohamad A Kalot, Nedaa M Husainat, et al.
Pageof 4